Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Sep;29(3):1160–1168. doi: 10.1128/iai.29.3.1160-1168.1980

Class-specific antibody responses to Mycoplasma pulmonis in sera and lungs of infected and vaccinated mice.

G Taylor, C J Howard
PMCID: PMC551253  PMID: 7429631

Abstract

Class-specific antibodies were measured by a solid-phase microradioimmunoassay in the sera and lung washings of mice after intranasal or intravenous inoculation with live Mycoplasma pulmonis and after systemic, intranasal, or combined vaccination with Formalin-inactivated mycoplasmas. After intranasal or intravenous inoculation with live organisms, serum antibodies were first detected in immunoglobulin M (IgM) followed by IgG2, IgG1, and IgA classes, but significant levels of IgA developed only in those mice inoculated intranasally. The appearance of antibodies in lung washings was later than in serum, but again these were predominantly IgG2 and IgG1. After inoculation with killed organisms, serum antibodies were predominantly IgG1, although IgG2, IgM, and, in intranasally vaccinated mice, IgA were also present. Only IgG1 was detected in lung washings from mice vaccinated systemically, but IgA and IgG2 were present in addition in animals vaccinated intranasally. Immunofluorescence studies indicated that some antibody in lung washings from the latter group of animals was produced locally. A comparison of the levels of various class-specific antibodies and resistance to intranasal challenge suggested that local antibody of any immunoglobulin class is capable of mediating resistance in the lungs to M. pulmonis infection.

Full text

PDF
1161

Images in this article

1165Fig. 2
on p.1165
1166Fig. 3
on p.1166

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brunner H., Greenberg H. B., James W. D., Horswood R. L., Couch R. B., Chanock R. M. Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers. Infect Immun. 1973 Oct;8(4):612–620. doi: 10.1128/iai.8.4.612-620.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cassell G. H., Lindsey J. R., Baker H. J. Immune response of pathogen-free mice inoculated intranasally with Mycoplasma pulmonis. J Immunol. 1974 Jan;112(1):124–136. [PubMed] [Google Scholar]
  3. Clyde W. A., Jr Immunopathology of experimental Mycoplasma pneumoniae disease. Infect Immun. 1971 Dec;4(6):757–763. doi: 10.1128/iai.4.6.757-763.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Denny F. W., Taylor-Robinson D., Allison A. C. The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice. J Med Microbiol. 1972 Aug;5(3):327–336. doi: 10.1099/00222615-5-3-327. [DOI] [PubMed] [Google Scholar]
  5. Ey P. L., Prowse S. J., Jenkin C. R. Complement-fixing IgG1 constitutes a new subclass of mouse IgG. Nature. 1979 Oct 11;281(5731):492–493. doi: 10.1038/281492a0. [DOI] [PubMed] [Google Scholar]
  6. Fernald G. W., Clyde W. A., Jr, Bienenstock J. Immunoglobulin-containing cells in lungs of hamsters infected with Mycoplasma pneumoniae. J Immunol. 1972 May;108(5):1400–1408. [PubMed] [Google Scholar]
  7. Fernald G. W., Clyde W. A. Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease. Infect Immun. 1970 Jun;1(6):559–565. doi: 10.1128/iai.1.6.559-565.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Greenberg H., Helms C. M., Grizzard M. B., James W. D., Horswood R. L., Chanock R. M. Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of route of administration on the immunogenicity and protective effect of inactivated M. pneumoniae vaccine. Infect Immun. 1977 Apr;16(1):88–92. doi: 10.1128/iai.16.1.88-92.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Howard C. J., Gourlay R. N., Taylor G. Immunity to Mycoplasma bovis infections of the respiratory tract of calves. Res Vet Sci. 1980 Mar;28(2):242–249. [PubMed] [Google Scholar]
  10. Lindsey J. R., Cassell H. Experimental Mycoplasma pulmonis infection in pathogen-free mice. Models for studying mycoplasmosis of the respiratory tract. Am J Pathol. 1973 Jul;72(1):63–90. [PMC free article] [PubMed] [Google Scholar]
  11. Taylor G., Howard C. J., Gourlay R. N. Protective effect of vaccines on Mycoplasma pulmonis-induced respiratory disease of mice. Infect Immun. 1977 May;16(2):422–431. doi: 10.1128/iai.16.2.422-431.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Taylor G. Immunity to mycoplasma infections of the respiratory tract: a review. J R Soc Med. 1979 Jul;72(7):520–526. [PMC free article] [PubMed] [Google Scholar]
  13. Taylor G. Solid-phase micro-radioimmunoassay to measure immunoglobulin class-specific antibody to Mycoplasma pulmonis. Infect Immun. 1979 Jun;24(3):701–706. doi: 10.1128/iai.24.3.701-706.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Taylor G., Taylor-Robinson D. Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice. Immunology. 1976 May;30(5):611–618. [PMC free article] [PubMed] [Google Scholar]
  15. Whittlestone P. Immunity to mycoplasmas causing respiratory diseases in man and animals. Adv Vet Sci Comp Med. 1976;20:277–307. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES